News | September 09, 2008

Carestream Molecular Imaging Expands Global Presence

September 10 — Carestream Molecular Imaging, a division of Carestream Health, Inc.is expanding its international presence with new dealer partnerships and a growing worldwide customer base, adding new dealer partners in Europe and the Middle East, the company reported at this week’s World Molecular Imaging Conference in Nice, France.

As part of its strategy to fill the demand for a cost effective and translatable molecular imaging solutions, the molecular imaging division has established new dealer partnerships with BioNova Cientifica, S.l. in Spain, Biosense S.R.L. in Italy, Csertex KFT in Hungary, and TransOrient Trading Co. in Palestine.

The company’s European dealer network is dedicated to increasing the presence of the company’s optical molecular imaging systems and fluorescent imaging agents to prominent pharmaceutical companies and research institutions. Partners such as Advanced Molecular Vision Ltd., AMV Germany, BioTech a.s., Csertex Ltd., Metis Biyoteknoloji and Metis-Turkey have been instrumental in the company’s recent customer successes in the following European institutions, such as Baxter AG, Charles University of Prague, Imperial College London’s Kennedy Institute of Rheumatology and several others.

Carestream Molecular Imaging is showcasing its portfolio of in vivo digital molecular imaging systems and imaging agents at the 2008 World Molecular Imaging Conference.
Carestream Health, an independent company, has licensed the KODAK brand for use with its own brands across its portfolio of leading-edge molecular imaging, medical imaging and healthcare IT products.

For more information: mi.carestreamhealth.com

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init